Eiken Chemical Co Ltd
TSE:4549

Watchlist Manager
Eiken Chemical Co Ltd Logo
Eiken Chemical Co Ltd
TSE:4549
Watchlist
Price: 3 465 JPY 1.02% Market Closed
Market Cap: ¥119.7B

Eiken Chemical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Eiken Chemical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Eiken Chemical Co Ltd
TSE:4549
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hoya Corp
TSE:7741
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hogy Medical Co Ltd
TSE:3593
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Asahi Intecc Co Ltd
TSE:7747
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mani Inc
TSE:7730
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nipro Corp
TSE:8086
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eiken Chemical Co Ltd
Glance View

Market Cap
119.7B JPY
Industry
Health Care

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. The company is headquartered in Taito-Ku, Tokyo-To and currently employs 733 full-time employees. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.

Intrinsic Value
1 976.47 JPY
Overvaluation 43%
Intrinsic Value
Price ¥3 465

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett